Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

3



Efficacy of transdermal rivastigmine for treatment hypersexuality in Alzheimer disease

Faik Ilik, Fatih Kayhan, Huseyin Buyukgol, Hatice Kose.

Abstract
Objective: Hypersexuality in Alzheimer's disease (AD) has been rarely investigated. No randomized clinical trials regarding the treatment of hypersexuality in demented people have been conducted, but available data from isolated case reports suggest the efficacy of selective serotonin reuptake inhibitors (SSRIs), antipsychotics, antiandrogens, and H2-receptor antagonists.
Method: The patient was a 72-year-old man, who presented for a neuropsychological evaluation performed at the Elbistan State Hospital with a Mini-Mental State Examination (MMSE) value of 18/30. The presenting symptom was persistent sexual desire. Transdermal rivastigmine was started at a dose of 5 (9mg) once daily and the sexual desires terminated on the second week of the treatment. Unfortunately, hypersexuality occurred 1 month later. Rivastigmine patch 10 (18 mg) was prescribed again to reduce the hypersexuality, and this proved to be effective.
Result: We present a case of a 72-year-old male patient with Alzheimer's disease with hypersexual behaviour as reported by his wife. Our patient exhibited significant improvement with rivastigmine.
Conclusion: Hypersexuality, also referred to in the literature as sexually inappropriate behavior and sexual disinhibition, involves persistent, uninhibited sexual behaviors directed at oneself or at others. In this case we would like to emphasize that cholinesterase inhibitors can be effective in treatment of hypersexuality in Alzheimer's disease.

Key words: hypersexuality, alzheimer's disease, rivastigmine, demantia, behavioral disease



Share this Article


Advertisement
Archives of Clinical and Experimental Surgery (ACES)

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
ScopeMed Home
Follow ScopeMed on Twitter
BiblioCAM
Author Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.
Scopemed Buttons